Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/
Unlock the market timeline & signal feed
121 signals in the last 90 days.
The order this company entered each market — oldest to newest
52 active postings
18 active postings
Sign up to see the full signal feed
How Teva Pharmaceuticals's international expansion compares to its competitors
Teva PharmaceuticalsYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Teva PharmaceuticalsYou | 19 | 1 | -15% | 109 | 32 |
Senior Manager Global Supply Planning
View postingSofia, Sofia City, Bulgaria · yesterday
Senior Director, Talent Management and Executive Recruitment 1
View postingParsippany, NJ · 3w ago
Director, Marketing - Launch Lead
View postingParsippany, NJ · 2w ago
Today, we announced Teva Pharmaceuticals’ Q1 2026 financial results, marking a strong start to the year and reinforcing our transformation into a leading biopharma company.Our key innovative products are becoming an engine of sustainable growth, collectively growing 41% year-over-year in local currency and continuing to shift Teva’s portfolio mix. We also saw continued progress on our late-stage innovative pipeline and stable generics performance driven by biosimilars growth. That's what our Piv ...
Active
Explore open roles at Teva India >>
Active
This post is directed to HCPs only.Looking for expert perspectives on the evolving role of long-acting injectables (LAIs) in improving the lives of people living with schizophrenia?Come along to the Forum Hall at 13.15 on Sunday 29th March during EPA 2026 in Prague to hear from an expert faculty as they consider the evolving evidence, opinion and guidelines supporting the wider integration of LAIs into clinical practice.13.15-14.15, Forum Hall (second floor)https://lnkd.in/eqRnEUpf Please do n ...
EndedTel Aviv Stock Exchange rose, with Tower Semiconductor and Teva leading gains. Bank Leumi declined on high turnover.
Teva Pharmaceutical forecasts lower revenue and profit for 2026 after three years of growth, with expected revenue of $16.4-16.8 billion and EPS of $2.55-2.65.
Teva Pharmaceutical's API division will eliminate 250 jobs in Israel over two years as part of operational adjustments, mainly affecting the Neot Hovav plant near Beersheva.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Teva Pharmaceuticals's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
